Hangzhou Biotest Biotech (688767.SH): Net profit for the year 2024 was 177 million yuan, a year-on-year increase of 65.74%.

Hangzhou Biotest Biotech (688767.SH) released its 2024 annual performance report, reporting a total operating income of 561 million yuan during the reporting period, a year-on-year increase of 26.80%; net profit attributable to the owners of the parent company was 177 million yuan, a year-on-year increase of 65.74%; net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 127 million yuan, a year-on-year increase of 59.35%; basic earnings per share were 1.68 yuan/share.